title: Physical basis behind achondroplasia, the most common form of human dwarfism.
abstract: Fibroblast growth factor receptor 3 (FGFR3) is a receptor tyrosine kinase that plays an important role in long bone development. The G380R mutation in FGFR3 transmembrane domain is known as the genetic cause for achondroplasia, the most common form of human dwarfism. Despite many studies, there is no consensus about the exact mechanism underlying the pathology. To gain further understanding into the physical basis behind the disorder, here we measure the activation of wild-type and mutant FGFR3 in mammalian cells using Western blots, and we analyze the activation within the frame of a physical-chemical model describing dimerization, ligand binding, and phosphorylation probabilities within the dimers. The data analysis presented here suggests that the mutation does not increase FGFR3 dimerization, as proposed previously. Instead, FGFR3 activity in achondroplasia is increased due to increased probability for phosphorylation of the unliganded mutant dimers. This finding has implications for the design of targeted molecular treatments for achondroplasia.
authors.affiliation: Department of Materials Science and Engineering, The Johns Hopkins University, Baltimore, Maryland 21218, USA.
authors.forename: Lijuan
authors.initials: L
authors.lastname: He
authors.forename: William
authors.initials: W
authors.lastname: Horton
authors.forename: Kalina
authors.initials: K
authors.lastname: Hristova
mesh_terms: D000130:Achondroplasia / Q000235:genetics / Q000378:metabolism* / Q000628:therapy; D019943:Amino Acid Substitution; D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D019281:Dimerization; D004789:Enzyme Activation; D006801:Humans; D008024:Ligands; D008954:Models, Biological; D020125:Mutation, Missense; D011485:Protein Binding; D051498:Receptor, Fibroblast Growth Factor, Type 3 / Q000235:genetics / Q000378:metabolism*
chemical_list: D008024:Ligands; C496365:FGFR3 protein, human; D051498:Receptor, Fibroblast Growth Factor, Type 3